Hallucination News and Research

RSS

A hallucination, in the broadest sense of the word, is a perception in the absence of a stimulus. In a stricter sense, hallucinations are defined as perceptions in a conscious and awake state in the absence of external stimuli which have qualities of real perception, in that they are vivid, substantial, and located in external objective space.

Lower metabolism, eating behavior possibly explain the cause of overweight in narcolepsy

A lower metabolism, as well as slight changes in eating behavior, could explain the positive energy balance leading to being overweight in narcolepsy, according to a study published in the October 1 issue of the journal SLEEP.

2 Oct 2007

Potential new treatment approach for schizophrenia

A new study reports important evidence for a potential new treatment approach for those diagnosed with schizophrenia.

25 Sep 2007

Antidepressant just as effective as antipsychotic in treating dementia

Research in Canada has revealed that when it comes to treating the aggressive behaviour seen in people with Alzheimer's disease, antidepressants work just as well as a commonly prescribed antipsychotic medication but without the severe side-effects.

11 Sep 2007

Antidepressant citalopram shows promise in treating symptoms of dementia

Researchers have found surprising evidence that an antidepressant (citalopram) may perform as well as a commonly-prescribed antipsychotic (risperidone) in the alleviation of severe agitation and psychotic symptoms of dementia.

11 Sep 2007

New and very different schizophrenia drug shows promise

Scientists at Eli Lilly say the first human trial of a new schizophrenia drug shows promise for sufferers of the debilitating mental illness.

3 Sep 2007

Risperdal approved for psychiatric conditions in children and adolescents

The U.S. Food and Drug Administration has approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.

24 Aug 2007

Antipsychotic drug Risperdal approved for use in children

The Food and Drug Administration (FDA) in the U.S. has given approval for the antipsychotic drug Risperdal to be used to treat schizophrenia and bipolar disorder in children and teenagers.

23 Aug 2007

FDA says cough and cold products used irresponsibly with children

The Food and Drug Administration (FDA) in the United States says it is concerned that cough and cold products sold over the counter (OTC) are being irresponsibly used particularly with children under the age of two.

20 Aug 2007

Persons with narcolepsy with cataplexy have low levels of protein thought to help regulate sleep

Persons with narcolepsy with cataplexy have low levels of cerebrospinal fluid (CSF) hypocretin-1, a protein thought to help regulate sleep and wakefulness, according to a study published in the August 1st issue of the journal SLEEP.

2 Aug 2007

Biological markers of narcolepsy

The first report to identify the biological markers of narcolepsy using gene expression in white blood cells finds that the MX2 gene, which is relevant to the immune system, is significantly less expressed in narcoleptics compared with normal subjects.

2 Aug 2007

Hallucinations in schizophrenia linked to brain area that regulates emotion and processes human voices

For the first time, researchers using magnetic resonance imaging (MRI) have found both structural and functional abnormalities in specific brain regions of schizophrenic patients who experience chronic auditory hallucinations, according to a study published in the August issue of Radiology.

1 Aug 2007

ADHD drug given to toddlers

Reports in the UK suggest that almost 400,000 youngsters aged between 5 and 19 are being treated with Ritalin and similar drugs for attention deficit hyperactivity disorder, or ADHD, regardless of fears about the drugs' serious side-effects such as cardiovascular disorders, hallucinations and even suicidal thoughts.

30 Jul 2007

Faster-acting antidepressant medications

A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work.

25 Jul 2007

Bipolar disorder shrinks the brain

British researchers have found that people who suffer from manic depression or bipolar disorder as it is more often called, also experience a loss of brain tissue and an accelerated shrinking of their brain.

21 Jul 2007

Bipolar disorder linked to reduction in brain tissue

People with bipolar disorder or manic depression suffer from an accelerated shrinking of their brain, researchers at the University of Edinburgh have found.

20 Jul 2007

People with early Parkinson's more likely to develop hallucinations, sleepiness and swelling

People with early Parkinson's disease report a higher than anticipated development or worsening of hallucinations, sleepiness, and swelling.

10 Jul 2007

People with narcolepsy have a high frequency of REM sleep without muscle atonia

Normal rapid eye movement (REM) sleep is characterized by tonic features, including cortical electroencephalogram (EEG) desynchronization and muscle atonia, as well as phasic events, including bursts of REM, phasic activities of both chin and limb electromyography (EMG), and cardiorespiratory variability.

4 Jul 2007